Werbung
Werbung
PCRX
Pacira BioSciences, Inc. Common Stock
23.54
USDGesponsert
-2.48
-9.52%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
23.54
-0.01
-0.04%
PCRX Ergebnisberichte
Positives Überraschungsverhältnis
PCRX übertreffen die 26 der letzten 40Schätzungen.
65%
Nächster Bericht
Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$204.67M
/$0.92
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+14.01%
/+31.43%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+9.30%
/+1.10%
Pacira BioSciences, Inc. Common Stock earnings per share and revenue
On 06. Nov. 2025, PCRX reported earnings of 0.70 USD per share (EPS) for Q3 25, beating the estimate of 0.66 USD, resulting in a 5.28% surprise. Revenue reached 179.52 million, compared to an expected 186.20 million, with a -3.59% difference. The market reacted with a +4.50% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of 0.92 USD, with revenue projected to reach 204.67 million USD, implying an increase of 31.43% EPS, and increase of 14.01% in Revenue from the last quarter.
FAQ
What were Pacira BioSciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Pacira BioSciences, Inc. Common Stock reported EPS of $0.70, beating estimates by 5.28%, and revenue of $179.52M, -3.59% below expectations.
How did the market react to Pacira BioSciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.5%, changed from $21.10 before the earnings release to $22.05 the day after.
When is Pacira BioSciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25. Feb. 2026.
What are the forecasts for Pacira BioSciences, Inc. Common Stock's next earnings report?
Based on 10
analysts, Pacira BioSciences, Inc. Common Stock is expected to report EPS of $0.92 and revenue of $204.67M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung